NCT07309250

Brief Summary

The goal of this study is to investigate the baseline of gastrointestinal transit time (GITT) and explore its relationship with other health indicators in 932 healthy adult volunteers. The main questions it aims to answer are: What are the population-level baseline values for GITT using the blue dye method? How is GITT associated with key physiological parameters including blood metabolic markers, life style, and stool characteristics? Participants will: Consume a standardized blue dye muffin after overnight fasting at the research center; Offer a finger prock blood samples for metabolic profiling; Collect stool samples for moisture measurement; Complete detailed questionnaires on diet, lifestyle, and bowel habits; Record the time of first blue stool appearance to determine GITT.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
932

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Dec 2025Dec 2026

First Submitted

Initial submission to the registry

November 17, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 30, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

December 30, 2025

Status Verified

December 1, 2025

Enrollment Period

1.1 years

First QC Date

November 17, 2025

Last Update Submit

December 15, 2025

Conditions

Keywords

Gastrointestinal motilityBaseline studyReference value

Outcome Measures

Primary Outcomes (1)

  • Gastrointestinal transit time

    Calculate the transit time by the recorded muffin consuming time, first blue stool appearance time and last blue stool appearance time

    From enrollment to the end of study at 2 weeks

Secondary Outcomes (17)

  • Height (cm)

    baseline

  • Weight (kg)

    baseline

  • BMI

    baseline

  • Blood glucose (mmol/L)

    baseline

  • Fat mass (kg)

    baseline

  • +12 more secondary outcomes

Study Arms (1)

Adult participants

Healthy adult participants without serious gastrointestinal diseases

Other: Diet

Interventions

DietOTHER

Participants will consume a regular muffin containing blue dye

Adult participants

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy volunteers from the Flanders region who volunteered to participate in the research

You may qualify if:

  • years old
  • kg/m² ≤ BMI ≤ 25 kg/m² or BMI ≥ 30 kg/m² (people with normal weight or obesity)
  • Provision of informed consent to participate.

You may not qualify if:

  • Gastrointestinal conditions which may affect nutrient absorption or gastric emptying, including coeliac disease, Crohn's disease, previous resection of the small intestine other than bariatric surgery, gastroparesis;
  • Using medications which effect gastric motility (e.g., domperidone, erythromycin, metoclopramide, prucalopride, opiates, loperamide, …)
  • The ingredients of blue muffins include gluten, nuts, baking powder, sugar, vanilla extract and sunflower oil. Participants with allergies to these ingredients;
  • Current diagnosis of cancer;
  • Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Child-Pugh B or C, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4;
  • Immobility;
  • Neuromuscular degenerative conditions associated with muscular atrophy, such as myasthenia gravis, muscular dystrophies, fibromyalgia, or multiple Sclerosis;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Chronic Diseases and Metabolism

Leuven, Flemish Brabant, 3000, Belgium

Location

MeSH Terms

Interventions

Diet

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
5 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 17, 2025

First Posted

December 30, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

December 30, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations